Rob Ring, Chief Scientific Officer, Autism Speaks
Dr. Ring currently serves as Chief Science Officer (CSO) for Autism Speaks, role he has held since June of 2013.
is a leading science and advocacy foundation founded in 2005, which has been responsible for funding over $280 million in research into causes, prevention and treatment of autism spectrum disorder (ASD).
A neuroscientist by training, Dr. Ring is responsible for leading the science program at Autism Speaks, which is focused on â€˜putting scientific breakthroughs to work for families.â€™ This program at Autism Speaks features a diverse portfolio of research investments targeting etiology & environmental science, medical research, public health, innovative technologies, and genomic discovery.
As CSO, Dr. Ring
has specifically helped launch Autism Speaks
signature genomics discovery program, MSSNG (aka â€˜Aut10Kâ€™ program), which has partnered with Google
to develop an unprecedented open-access database of genomic sequence information to support the autism research ecosystem.
Dr. Ring joined Autism Speaks in 2011 as vice president and Head of Translational Research.
In this previous role, Dr. Ring was responsible for launching the foundationâ€™s innovative venture philanthropy arm Delivering Scientific Innovation for Autism (aka â€˜DELSIAâ€™), which support entrepreneurs and early stage companies developing products that address unmet needs of the ASD community.
Dr. Ring has served as a public member of the Interagency Autism Coordinating Committee (IACC), the federal advisory committee that coordinates all efforts within the Department of Health and Human Services (HHS) concerning ASD.
Prior to joining Autism Speaks, Dr. Ring was a Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Connecticut.
It was there he led the first dedicated research group in the pharmaceutical industry focused specifically on the discovery and development of medicines for neurodevelopmental disorders, specifically Autism Spectrum Disorders.
Prior to Pfizer
, Dr. Ring distinguished worked for over 10 years in psychiatric medicines discovery and development at Wyeth Research
in Princeton, NJ.
holds separate adjunct faculty appointments in the Department of Psychiatry at Mount Sinai School of Medicine (New York) and Department of Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia).